{"id":"https://openalex.org/W4379280705","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e21112","title":"Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).","display_name":"Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379280705","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e21112"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.e21112","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e21112","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21112","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083477114","display_name":"Muhammad Furqan","orcid":"https://orcid.org/0000-0003-3137-2053","observed_orcids":["https://orcid.org/0000-0003-3137-2053"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Furqan","raw_affiliation_strings":["University of Iowa, Carver College of Medicine, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa, Carver College of Medicine, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064802547","display_name":"Siddharth S. Karanth","orcid":"https://orcid.org/0000-0002-4923-2692","observed_orcids":["https://orcid.org/0000-0002-4923-2692"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siddharth Karanth","raw_affiliation_strings":["RTI Health Solutions, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Research Triangle Park, NC","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070844863","display_name":"RK Goyal","orcid":"https://orcid.org/0000-0003-1632-036X","observed_orcids":["https://orcid.org/0000-0003-1632-036X"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi K. Goyal","raw_affiliation_strings":["RTI Health Solutions, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Research Triangle Park, NC","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005748248","display_name":"Yu-Hsuan Shih","orcid":"https://orcid.org/0000-0002-9823-3771","observed_orcids":["https://orcid.org/0000-0002-9823-3771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Hsuan Shih","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038383749","display_name":"Beilei Cai","orcid":"https://orcid.org/0000-0002-2762-3908","observed_orcids":["https://orcid.org/0000-0002-2762-3908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beilei Cai","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083140","display_name":"Julien Rombi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julien Rombi","raw_affiliation_strings":["RTI Health Solutions, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000219240","display_name":"Keith L. Davis","orcid":"https://orcid.org/0000-0002-0044-7107","observed_orcids":["https://orcid.org/0000-0002-0044-7107"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith L. Davis","raw_affiliation_strings":["RTI Health Solutions, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI Health Solutions, Research Triangle Park, NC","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071806312","display_name":"Nydia Caro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nydia Caro","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036815013","display_name":"Teddy Rassem Saliba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teddy Rassem Saliba","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"e21112","last_page":"e21112"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capmatinib","display_name":"capmatinib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/met-exon-14-skipping","display_name":"MET exon 14 skipping","score":0.9340000152587891},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.7250000238418579},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9139999747276306},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9490000009536743},{"id":"https://openalex.org/keywords/time-to-treatment-discontinuation","display_name":"time to treatment discontinuation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/met-inhibitors","display_name":"MET inhibitors","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9522263407707214},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6522610783576965},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.642078161239624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6401702165603638},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5644813776016235},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5116665363311768},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4178084135055542},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.41260528564453125},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4008128046989441},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.28626784682273865},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.e21112","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e21112","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21112","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416346411","https://openalex.org/W4281848104","https://openalex.org/W4285205924","https://openalex.org/W4394872876","https://openalex.org/W3171766723","https://openalex.org/W4295828550","https://openalex.org/W3127178332","https://openalex.org/W7167465569","https://openalex.org/W4401836290","https://openalex.org/W4387825444"],"abstract_inverted_index":{"e21112":[0],"Background:":[1],"Capmatinib":[2],"is":[3,16],"approved":[4,26],"for":[5,81],"patients":[6],"(pts)":[7],"with":[8,36,38,43,77,107,249,273],"advanced":[9],"stage":[10,93],"(a)NSCLC":[11],"harboring":[12],"METex14.":[13],"However,":[14],"there":[15],"limited":[17],"data":[18,57,122],"on":[19],"capmatinib":[20,82,222,252,270,293],"activity":[21],"in":[22,67,208,243,271,286,294,303],"comparison":[23],"to":[24,152],"other":[25,131,257],"therapies.":[27,85],"We":[28],"assessed":[29,158,177],"real-world":[30],"(rw)":[31],"clinical":[32,278,300],"outcomes":[33,135,175,279],"of":[34,63,75,110,120,180,292],"pts":[35,87,190,212,233],"aNSCLC":[37,272],"METex14":[39,274],"who":[40,70,219,234],"initiated":[41],"treatment":[42,153],"capmatinib,":[44],"immunotherapy":[45],"(IO),":[46],"or":[47,166,239,242,282,285],"chemotherapy":[48],"(CT)":[49],"regimens.":[50],"Methods:":[51],"In":[52,186],"a":[53,61,261],"retrospective":[54],"chart":[55],"review,":[56],"were":[58,88,171,176,191,199,202,206],"abstracted":[59],"by":[60,162],"sample":[62],"oncologists":[64],"invited":[65],"nation-wide":[66],"the":[68,121],"US":[69],"randomly":[71],"selected":[72],"prespecified":[73],"numbers":[74],"charts,":[76],"larger":[78],"sampling":[79],"targets":[80],"and":[83,96,125,150,204,226,230,297],"IO":[84,237,281],"Eligible":[86],"aged":[89],"\u226518":[90],"years,":[91,197],"had":[92,213,223,253],"\u2265IIIB":[94],"NSCLC":[95],"METex14;":[97],"received":[98,220,235],"first-line":[99],"(1L)":[100],"systemic":[101],"therapy":[102,116,181],"after":[103,113],"1":[104],"January":[105],"2017":[106],"follow":[108],"up":[109],"\u22656":[111],"months":[112],"starting":[114],"1L":[115,221,236],"(except":[117],"death)":[118],"as":[119],"abstraction":[123],"date;":[124],"did":[126],"not":[127],"receive":[128],"MET":[129],"inhibitors":[130],"than":[132,232,256,280],"capmatinib.":[133],"Clinical":[134],"included":[136],"best":[137],"overall":[138,147],"real":[139],"world":[140],"response":[141],"rate":[142],"(rwORR),":[143],"progression-free":[144],"survival":[145,148],"(rwPFS),":[146],"(OS),":[149],"time":[151],"discontinuation":[154],"(TTD).":[155],"RwORR":[156],"was":[157,195,260],"using":[159],"rw-RECIST":[160],"guided":[161],"RECIST":[163],"1.1":[164],"criteria":[165],"physician":[167],"documentation.":[168],"All":[169],"measures":[170],"descriptively":[172],"analyzed.":[173],"Time-to-event":[174],"per":[178],"line":[179],"via":[182],"Kaplan-Meier":[183],"methods.":[184],"Results:":[185],"total,":[187],"287":[188],"eligible":[189],"identified.":[192],"Median":[193],"age":[194],"63.3":[196],"71%":[198],"male,":[200],"41%":[201],"non-White,":[203],"49.5%":[205],"treated":[207,248],"community":[209],"settings.":[210],"15":[211],"brain":[214],"metastasis":[215],"at":[216],"diagnosis.":[217],"Pts":[218,247],"higher":[224,254],"rwORR":[225,255],"longer":[227],"rwPFS,":[228],"OS,":[229],"TTD":[231],"mono":[238],"CT":[240,283],"alone":[241,284],"combination":[244],"(Table":[245],"1).":[246],"second-line":[250],"(2L)":[251],"treatments":[258],"but":[259],"smaller":[262],"pt":[263],"population.":[264],"Conclusions:":[265],"Our":[266],"analysis":[267],"suggests":[268],"that":[269],"yields":[275],"numerically":[276],"better":[277],"combination.":[287],"These":[288],"findings":[289],"support":[290],"use":[291],"this":[295],"setting":[296],"may":[298],"inform":[299],"decision":[301],"making":[302],"routine":[304],"practice.":[305],"[Table:":[306],"see":[307],"text]":[308]},"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2023-06-05T00:00:00"}